Drug Trial Radar · NCT01367249
Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery
Last checked: Nov 20, 2026Latest source record: May 6, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
440
Actual
Start
May 2011
Primary completion
Jul 2011
Study completion Dec 2011
Sponsor
- Lead sponsor
- Bausch & Lomb IncorporatedIndustry
- Sponsor type
- Industry
- First posted
- Jun 7, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an efficacy study of Bromfenac Ophthalmic Solution in cataract surgery.
Conditions
- Pain
- Inflammation
- Cataract
Interventions
Bromfenac Ophthalmic SolutionDrug
Sterile ophthalmic solution
PlaceboDrug
Sterile ophthalmic solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- Ocular InflammationTime frame: Day 15
Locations
1 site in 1 country. Site status is shown where the registry gives one.
ISTA Pharmaceuticals, Inc.
Irvine, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.